Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhlis Cem Ar

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Cancer Management and Research|June 14, 2022
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two DecadesSimay Çokgezer, Tuğrul Elverdi, Ayşe Salihoğlu, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2011
Essential thrombocythemia and multiple myeloma: two rare diseases in one patientAhmet Emre Eskazan, Seniz Ongoren, Muhlis Cem Ar, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 27, 2025
Real-World Clinical Outcomes and Prognostic Factors in Acquired Hemophilia A: A Single-Center Retrospective AnalysisSelin Küçükyurt Kaya, Pelin Öztürk, Umut Yılmaz, et al.
European Journal of Dermatology : EJD|October 24, 2007
Alemtuzumab in Sézary syndrome: efficient but not innocentUmit Barbaros Ure, Muhlis Cem Ar, Ayse Salihoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2026
Impact of Systemic Inflammatory and Autoimmune Diseases on Outcomes in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaSelin Cebeci, Emir Serraç, Tuğrul Elverdi, et al.
Annals of Hematology|August 2, 2020
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic countryAhmet Murt, Tugrul Elverdi, Ahmet Emre Eskazan, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 26, 2024
Complications of therapeutic plasma exchange: A retrospective, single-center study of 2505 procedures performed in 338 patients over 15 yearsEce Vural, Tuğrul Elverdi, Ayşe Salihoğlu, et al.
Leukemia Research|August 29, 2023
Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectivesMuhlis Cem Ar, Riad El Fakih, Saule Gabbassova, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 28, 2020
The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromesAhmet Sarici, Muhlis Cem Ar, Osman Yokus, et al.
European Journal of Haematology|July 20, 2013
Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patientMurat Ozbalak, Ilyas Tokatlı, Metin Özdemirli, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Cancer Management and Research|June 14, 2022
Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two DecadesSimay Çokgezer, Tuğrul Elverdi, Ayşe Salihoğlu, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2011
Essential thrombocythemia and multiple myeloma: two rare diseases in one patientAhmet Emre Eskazan, Seniz Ongoren, Muhlis Cem Ar, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|August 27, 2025
Real-World Clinical Outcomes and Prognostic Factors in Acquired Hemophilia A: A Single-Center Retrospective AnalysisSelin Küçükyurt Kaya, Pelin Öztürk, Umut Yılmaz, et al.
European Journal of Dermatology : EJD|October 24, 2007
Alemtuzumab in Sézary syndrome: efficient but not innocentUmit Barbaros Ure, Muhlis Cem Ar, Ayse Salihoglu, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2026
Impact of Systemic Inflammatory and Autoimmune Diseases on Outcomes in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic LeukemiaSelin Cebeci, Emir Serraç, Tuğrul Elverdi, et al.
Annals of Hematology|August 2, 2020
Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic countryAhmet Murt, Tugrul Elverdi, Ahmet Emre Eskazan, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 26, 2024
Complications of therapeutic plasma exchange: A retrospective, single-center study of 2505 procedures performed in 338 patients over 15 yearsEce Vural, Tuğrul Elverdi, Ayşe Salihoğlu, et al.
Leukemia Research|August 29, 2023
Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectivesMuhlis Cem Ar, Riad El Fakih, Saule Gabbassova, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 28, 2020
The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromesAhmet Sarici, Muhlis Cem Ar, Osman Yokus, et al.
European Journal of Haematology|July 20, 2013
Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patientMurat Ozbalak, Ilyas Tokatlı, Metin Özdemirli, et al.
Pageof 11